ESROLAS
Live / Registered — Registered (as of 21 Oct 2025)
What this means for you
Registered since 21 Oct 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90583044
- Registration number
- 7995029
- Mark type
- Stylized text
- Filed
- 16 Mar 2021
- Published for opposition
- 23 Nov 2021
- Registered
- 21 Oct 2025
- Attorney of record
- Karen A. Webb
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of breast cancer
Owner
- Sermonix Pharmaceuticals, Inc., Columbus, OH, US
- Sermonix Pharmaceuticals, Inc., Columbus, OH, US
- Sermonix Pharmaceuticals, Inc., Columbus, OH, US
Prosecution history
- 21 Oct 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 21 Oct 2025 — REGISTERED-PRINCIPAL REGISTER
- 26 Sept 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 26 Sept 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Sept 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 02 Sept 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 02 Sept 2025 — ASSIGNED TO LIE
- 25 Aug 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 27 May 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 27 May 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 27 Feb 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 27 Feb 2025 — NON-FINAL ACTION E-MAILED
- 27 Feb 2025 — SU - NON-FINAL ACTION - WRITTEN
- 31 Jan 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 15 Nov 2024 — USE AMENDMENT FILED